Bernard V. North

St. Mary's Campus, Praed Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods.

Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods.

Journal: BMJ open
Published: December 10, 2025

Improved stage-specific survival in screen-detected breast cancer in Denmark: a cohort study.

Improved stage-specific survival in screen-detected breast cancer in Denmark: a cohort study.

Journal: Journal of the National Cancer Institute
Published: September 08, 2025

Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study.

Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study.

Journal: BMJ open
Published: February 11, 2025

Impact of mode of offer of self-sampling to people overdue cervical screening on screening participation: a randomised controlled trial.

Impact of mode of offer of self-sampling to people overdue cervical screening on screening participation: a randomised controlled trial.

Journal: EClinicalMedicine
Published: November 18, 2024

Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen).

Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen).

Journal: EClinicalMedicine
Published: January 28, 2024

Reply to R. Sun et al.

Reply to R. Sun et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 21, 2023

Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk.

Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk.

Journal: BMJ open
Published: September 07, 2023

Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer.

Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer.

Journal: Cancer research communications
Published: February 24, 2023

Years of life lost due to cancer in the United Kingdom from 1988 to 2017.

Years of life lost due to cancer in the United Kingdom from 1988 to 2017.

Journal: British journal of cancer
Published: January 17, 2023

Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.

Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.

Journal: BMC cancer
Published: February 28, 2022

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.

Journal: Cancer cell
Published: October 22, 2021

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

Journal: The Lancet. Oncology
Published: March 11, 2021
Showing 1-12 of 29

Last Updated: 09/26/2026